Antonio Ciaramella

Alzheimers Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels

Francesco Angelucci, Gianfranco Spalletta, Fulvia Di Iulio et al. · Current Alzheimer Research · 2010 · 179 citations

Neurochemical Biomarkers, Alzheimer's Disease, Bdnf Peripheral Levels +16

IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease

Paola Bossù, Detlef Neumann, Elda Del Giudice et al. · Proceedings of the National Academy of Sciences · 2003 · 122 citations · Full text

Interleukin-18 produced by peripheral blood cells is increased in Alzheimer’s disease and correlates with cognitive impairment

Paola Bossù, Antonio Ciaramella, Francesca Salani et al. · Brain Behavior and Immunity · 2007 · 110 citations

Inflammation, Neurodegenerative Diseases, Alzheimer's Disease +10

Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury

Stefania Mondello, Andrea Gabrielli, Sheila Catani et al. · Brain Injury · 2012 · 63 citations

Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease

Paola Bossù, Antonio Ciaramella, Maria Luisa Moro et al. · Journal of Neurology Neurosurgery & Psychiatry · 2007 · 63 citations · Full text